
Digitalis Ventures is a venture capital firm that invests in solutions to complex problems in human and animal health. The firm provides capital to early-stage companies across life sciences, biotechnology, and healthcare technology.
35% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (40% of deals). Average disclosed round size is $59.5M (across 44 rounds with reported amounts).
Portfolio
45
Fund Size
$300M
Top Stage
Series A
Last 12 Mo
3
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
48 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series B | $130M | Dec 2025 | |
| Series B | $130M | Dec 2025 | |
| Unknown | $25M | Oct 2025 | |
| Seed | — | Jul 2025 | |
| Unknown | $18M | Jul 2025 | |
| AAviceda Therapeutics | Series C | — | Jan 2025 |
| Series B | $161M | Dec 2024 | |
| Series C | $175M | Oct 2024 | |
| AAlpha-9 Oncology, Inc. | Series C | $175M | Oct 2024 |
| AAlpha-9 | Series C | $175M | Oct 2024 |
| Series B | $260M | Jul 2024 | |
| Series B | $26M | May 2024 | |
| AAlterome Therapeutics, Inc. | Series B | $35M | Apr 2024 |
| Series A | $24M | Mar 2024 | |
| AAlpha-9 Oncology, Inc. | Series C | $175M | Jan 2024 |
| AAscend Gene & Cell Therapies | Series A | $132.5M | May 2023 |
| Seed | $6M | Apr 2023 | |
| AAscend Advanced Therapies | Series A | $132.5M | Mar 2023 |
| Series B | $41M | Nov 2022 | |
| Series A | $47M | Jun 2022 | |
| Series A | $60M | Feb 2022 | |
| Seed | $20M | Jan 2022 | |
| Series A | $5M | Jan 2022 | |
| Series A | $25M | Oct 2021 | |
| Series A | $15M | May 2021 |
Page 1 of 2
Top Co-Investors
Longitude Capital6 shared
Lightspeed Venture Partners6 shared
Two Sigma Ventures6 shared
Delos Capital5 shared
Omega Funds5 shared
Alexandria Venture Investments5 shared
General Catalyst4 shared
Samsara BioCapital4 shared
Frazier Life Sciences4 shared
RA Capital Management4 shared
S2G Ventures4 shared
Cantos4 shared
Future Fund4 shared
Koch Disruptive Technologies4 shared
Khosla Ventures4 shared
OrbiMed4 shared
Brewer Lane Ventures4 shared
Founder Collective4 shared
Nextech Invest4 shared
Blue Owl Capital3 shared
Last updated: 8 September 2026